When engineers here at Honda R&D were discussing where to locate the “engine start” button in their vehicles, they learned that several US drivers accidentally pressed the engine start button with their knees.
This was a big surprise for us, because it’s only possible if you put the car into cruise control, take your feet off the pedals and fold your legs up on the seat. We had never imagined that people would actually choose to drive like this, so it was a valuable insight for our product design teams.
This insight and others like them come from analyzing records from the National Highway Traffic Safety Administration (NHTSA). We also glean information from J.D. Power Initial Quality Studies, Honda R&D’s in-house voice-of-customer studies, vehicle diagnostics and telematics, smartphones, biometric sensors, and sources of unstructured text, such as customer surveys.
The IBM cloud enabled us to get the solution up and running much more quickly than would have been possible with an on-premises solution. What’s more, the scalability of the platform means that if other departments decide to adopt IBM Watson Content Analytics, Honda R&D can add and support them easily.
Big data insights are also propelling new engineering projects at Honda R&D, such as using vehicle sensor data to monitor drivers’ steering manoeuvers and potentially personalize the steering experience.
IBM analytics is helping Honda R&D’s engineers harness big data to explore valuable new areas of research — and ultimately design better, smarter, safer automobiles.
(Part 2 in a Series) We have been partnering with and assisting clients on their data needs and strategies for years. It’s clear that data and AI are two-sides of the same coin; in fact, this understanding spawned the AI Ladder concept. We’ve developed skills training in the areas of data science and machine learning; […]
The journal Health Affairs estimates that the U.S. spends nearly $500 billion annually on pharmaceutical treatments. Focusing on clinical value alone isn’t enough to meet business growth targets — customer experience plays a critical role in long-term brand success. But experience doesn’t occur in isolation: To win trust and boost spending, pharma brands must use […]
Chronic kidney disease (CKD) is one of the most severe secondary complications related to diabetes. It is characterized by the progressive loss of the kidney function, beginning with a decline in the glomerular filtration rate and/or albuminuria, eventually resulting in end-stage renal disease. This severe complication often requires dialysis or renal transplant therapy. In January […]